Essential Thrombocythemia - A Cause of Myocardial Infarction in a Young Male

Journal of Association of Physicians of India

Volumn 49, Issue APR, 2001, Pages 473-474

  Ghotekar, L H ^a   Dutta, T K ^a   Kumarasamy, V ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; HEPARIN; HYDROXYUREA;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; RISK ASSESSMENT; THROMBOCYTOSIS; TREATMENT OUTCOME;

ADULT; BLOOD CHEMICAL ANALYSIS; CARDIOTONIC AGENTS; CASE REPORT; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEPARIN; HUMAN; HYDROXYUREA; MALE; MYOCARDIAL INFARCTION; RISK ASSESSMENT; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 0035321847     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Fialkow PJ, Faguet GB, Jacobson RJ, et al. Evidence of essential thrombocythemia is a clonal disorder with origin in an multipotent stem cell. Blood 1981; 58 : 916.
2. Ross C, Randi ML, Zerbinate P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia vera. J Internal Med 1998; 244 : 49-53.
3. Lofunberg E, Wahlin A. Management of polycythemia vera, essential thrombocythemia and myelofibrosis with hydroxyurea. Eur J Haematol 1988; 41 : 375.
4. Van de Pett EW, Prochazka AV, Pearson TC, et al. Primary thrombocythemia treated with busulfan. Br J Haematol 1986; 26 : 229.
5. Wehmeier A, Sudholf T, Meirkord F. Relation of platelet abnormalities to thrombosis and Hg in chronic myeloproliferative disorder. Semin Thromb Hemost 1997; 23 : 391-402.
6. Murray N, Silverstein, Ayalew Teffari. Treatment of ET with anagrelide. Seminars in Haematology. 1999; 36 (Suppl. 2) : 23-7.